This means its absorbed faster
While technically not a pure GLP-1 agonist, tirzepatide produces substantial weight loss (1520%) and marked metabolic improvements, with emerging evidence of significant hepatic fat reduction

15 Beyond Weight Loss: The Broader Promise of GLP-1s 17 Challenges, Risks, and Considerations 20 Introduction Over the past several decades, the United States has made significant progress in many population health indicators, including increased life expectancy, reduced smoking rates, and decreased substance use among youth.[1] However, in stark contrast, obesity rates have surged, nearly doubling since the early 2000s.[2] Obesity now affects 42.4 percent of American adults, making it a significant driver of both preventable disease and health care costsan estimated $173 billion annually, according to the Centers for Disease Control and Prevention (CDC).[3] The United States also faces rising obesity among children and adolescents, with nearly one in five youth classified as obese.[4] Obesity is commonly defined as a body mass index (BMI) of 30 kg/m or higher.[5] This trend is not unique to the United States, as rising obesity rates have been observed across many countries worldwide

Baskol, G., Baskol, M
\ La tirzepatida funciona mejor como parte de un plan integral
Semaglutide can promote modest sodium losses through increased urination and changes in fluid balance as weight decreases